Zalutumumab Terminated Phase 2 Trials for Non-Small Cell Lung Carcinoma (NSCLC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00460551Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer